Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulating therapeutic approaches for multiple sclerosis

D M Karussis1, O Abramsky

  • 1Department of Neurology, Hadassah-Hebrew University Hospital, Jerusalem, Israel.

Journal of the Neurological Sciences
|March 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2010
Same author

[256 scientific ties between Jews and Germans, Israel and Germany from the 20th century until today Conference held in Jerusalem on November 17th 2008].

Harefuah·2010
Same author

Immunologic characterization of oligodendroglia.

Neuroscience letters·2009
Same author

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

Lancet (London, England)·2008
Same author

Lack of hemispheric localizing value of the palmomental reflex.

Neurology·2005
Same author

Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2005

This review explores immunotherapy for multiple sclerosis (MS), detailing immune intervention strategies. It discusses current and future treatments targeting antigen presentation, lymphocytes, and cytokine networks for MS management.

Area of Science:

  • Neuroimmunology
  • Immunotherapy
  • Multiple Sclerosis (MS)

Background:

  • Multiple sclerosis is a chronic autoimmune disease affecting the central nervous system.
  • Understanding the immune system's role is crucial for developing effective MS treatments.

Purpose of the Study:

  • To review the rationale for immunotherapy in multiple sclerosis.
  • To describe feasible immune intervention levels based on a modern immune system model.

Main Methods:

  • Discussion of current and future immunosuppressive therapies.
  • Analysis of immunomodulating approaches targeting specific immune components.

Main Results:

  • Identification of multiple intervention levels within the immune system for MS.

Related Experiment Videos

  • Overview of therapeutic strategies at antigen presentation, lymphocyte, and cytokine network levels.

    • Conclusions:

    • Immunotherapy offers a promising avenue for managing multiple sclerosis.
    • Targeted interventions at various immune system levels can be developed for MS treatment.